Russian Heart Failure Journal 2011year 24‑hour ambulatory blood pressure monitoring in patients with chronic heart failure


To access this material please log in or register

Register Authorize
2011/

24‑hour ambulatory blood pressure monitoring in patients with chronic heart failure

Serov V. A., Shutov A. M., Troshenkina O. V., Makeeva E. R., Serova D. V., Kuznetsova Y. S.

Keywords: BP monitoring, CHF, hypertension

DOI: 10.18087/ rhfj.2011.4.1504

Background. Despite the obvious advantages over office BP measurement 24‑hour ambulatory blood pressure monitoring (ABPM) in patients with HF is the exception, and the role of ABPM for assessment of efficacy and safety of CHF treatment is still unclear. Objective. To study ABPM advantages over BP office measurement in patients with CHF. Materials and methods. The study included 177 CHF patients (97 men and 80 women) aged 56.7 years. 19 patients had CHF FC I, 100 – II FC, 57 – III FC and 1 – IV FC. The cause of CHF was hypertension (AH) in 49 patients, ischemic heart disease – in 4, the combination of CAD and AH – in 122, other heart disease – in 2 patients. ABPM was conducted on devices MnSDP-2 and MnSDP BPLab (OOO «Peter Telegin», Russia). Results. Office BP measurement revealed systolic and diastolic AH in 56.5 % of patients with CHF, isolated systolic hypertension – in 11.9 %, isolated diastolic hypertension – in 7.3 % of patients. ABPM revealed AH more frequently. Normal BP levels were observed in 24.3 % of patients with office measurement, while at the same time, in 5.1 % of patients with ABPM, and hypotension – in 6.8 % in 74.6 % of CHF patients, respectively. Violations of the degree of nocturnal SBP reduction were found in 68.9 %, DBP – in 62.1 % of patients. This results showed that ABPM in patients with CHF can significantly increase the frequency of detection of potentially dangerous BP changes – arterial hyper-and hypotension. ABPM can provide information about nature of BP circadian rhythm violations associated with target organ damage. It is necessary to conduct prospective clinical trials to determine prognostic significance of violations of BP daily profile in patients with CHF and decide whether to include ABPM into examination plan of CHF patients.
  1. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр). Журнал Сердечная Недостаточность. 2010;11 (1):3–62.
  2. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29 (19):2388–2442.
  3. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol. 2007;23 (1):21–45.
  4. ACC / AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112 (12):e154–235.
  5. Фомин И. В. Эпидемиология хронической сердечной недостаточности в Европейской части Российской Федерации. – В кн. «Хроническая сердечная недостаточность». – М, 2010. – 7–76с.
  6. Lee DS, Ghosh N, Floras JS et al. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure. Circ Heart Fail. 2009;2 (6):616–623.
  7. Горбунов В. М. Некоторые вопросы практического использования суточного мониторирования артериального давления. Клиницист. 2008;1 (3):30–40.
  8. Рогоза А. Н., Никольский В. П., Ощепкова Е. В. и др. Суточное мониторирование артериального давления (методические вопросы). Г. Г. Арабидзе и О. Ю. Атьков (ред.). – М., 1997. – 33с.
  9. Owens PE, O’Brien ET. Hypotension: a forgotten illness? Blood Press Monit. 1997;2 (1):3–14.
  10. Levy D, Larson M, Vasan R et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275 (20):1557–1562.
  11. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G. Heart failure in the general population of men: morbidity, risk factors and prognosis. J Intern Med. 2001;249 (3):253–261.
  12. Haider AW, Larson MG, Franklin SS et al. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138 (1):10–16.
  13. Lee TT, Chen J, Cohen DJ, Tsao L. The association between blood pressure and mortality in patients with heart failure. Am Heart J. 2006;151 (1):76–83.
  14. Güder G, Frantz S, Bauersachs J et al. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ Heart Fail. 2009;2 (6):563–571.
  15. Raphael CE, Whinnett ZI, Davies JE et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart ­failure. Heart. 2009;95 (1):56–62.
  16. Gheorghiade M, Abraham WT, Albert NM et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296 (18):2217–2226.
  17. D’Agostino RB, Belanger AJ, Kannel WB, Cruickshank JM. Relation of low diastolic blood pressure to coronary heart disease death in ­presence of myocardial infarction: the Framingham Study. BMJ. 1991;303 (6799):385–389.
  18. Bangalore S, Qin J, Sloan S et al. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122 (21):2142–2151.
  19. Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol. 2009;54 (20):1827–1834.
  20. Grigorian-Shamagian L, Gonzalez-JuAnatey JR, Vazquez R et al. Associ­ation of blood pressure and its evolving changes with the survival of patients with heart failure. J Card Fail. 2008;14 (7):561–568.
  21. Anand IS, Rector TS, Kuskowski M et al. Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial. Circ Heart Fail. 2008;1 (1):34–42.
  22. Hoshide S, Kario K, Hoshide Y et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16 (6):434–438.
  23. Ingelsson E, Bjorklund-Bodegard K, Lind L et al. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006;295 (24):2859–2866.
  24. Shin J, Kline S, Moore M et al. Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure. J Card Fail. 2007;13 (8):656–662.
Serov V. A., Shutov A. M., Troshenkina O. V. et al. 24‑hour ambulatory blood pressure monitoring in patients with chronic heart failure. Russian Heart Failure Journal. 2011;12(4):196-200.

To access this material please log in or register

Register Authorize
Ru En